Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01155583 · COMPLETED
Trial details
- NCT number
- NCT01155583
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2016-05-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.